Terumo

What Terumo does

Terumo Medical do Brasil is the Brazilian operating subsidiary of Terumo Corporation, the Japanese medical device manufacturer founded in 1921. Established in Brazil in 1999, the entity distributes a diversified medical device portfolio organized into four divisions: Terumo Interventional Systems (coronary stents, PTCA balloons, guidewires, microcatheters, vascular closure devices, and OFDI imaging); Terumo Cardiovascular (CAPIOX hollow fiber oxygenators, centrifugal pumps, cardioplegia systems, and hemoconcentrators for cardiac surgery and extracorporeal circulation); Terumo Hospital Care Solutions (Terufusion infusion pumps, anesthesia pumps, syringes, hypodermic needles, and administration sets); and Terumo Pharmaceutical Solutions (drug administration devices including safety syringes and infusion sets). The technical platform rests on proprietary in-house innovations such as hollow fiber membrane manufacturing for oxygenation, M Coat hydrophilic coating for interventional devices, the Midpress infusion mechanism, and CAPIOX non-occlusive centrifugal pump control.

The company serves Brazilian and broader Latin American healthcare providers — primarily hospitals, cardiovascular surgery centers, and interventional cardiology departments — through a direct enterprise field sales model organized by product division, complemented by an event-driven GTM focused on major Brazilian medical congresses (Feira Hospitalar, PCI Experience, SBHCI, and others). Distribution is handled through two national distribution centers in Extrema (Minas Gerais) and Atibaia (São Paulo), with commercial operations anchored from the São Paulo headquarters. The entire Brazilian product range is registered with ANVISA and operates under LGPD data protection compliance.

Commercially, Terumo Medical do Brasil operates as a B2B hardware vendor with a razor-and-blade extension model in infusion therapy (Terufusion pumps are designed exclusively for use with proprietary Terumo administration sets, including latex-free and DEHP-free variants). Pricing is not publicly disclosed and is handled through direct sales contact. As a wholly-owned subsidiary of Terumo Corporation — itself a global entity operating in 160+ countries — the Brazilian entity reports through parent-level corporate governance and contributes to Terumo Corporation's Latin American footprint rather than operating as an independent investment vehicle; there are no external investors or funding rounds disclosed.

Name

Terumo

Legal name

Terumo Medical do Brasil

Website

https://terumo.com.br

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Terumo Medical do Brasil is a wholly-owned subsidiary of Japan's Terumo Corporation, manufacturing and distributing medical devices across four divisions — interventional cardiology, cardiovascular surgery, hospital infusion systems, and pharmaceutical administration — to Brazilian and LATAM healthcare providers through direct sales.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Single-Use Surgical Devices & Procedure Packs (Disposable instruments, drapes, kits) (HLAHADAM)

akta.pro secondary industry

Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)

Keywords

• Medical devices
• Interventional cardiology
• Hospital infusion systems
• Cardiovascular surgery
• Pharmaceutical administration

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales: Terumo generates revenue primarily through the sale of medical devices and equipment including interventional systems, cardiovascular products, hospital care solutions, and pharmaceutical administration devices to healthcare providers.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Terumo Medical do Brasil manufactures and distributes a portfolio of medical devices spanning four product divisions: Terumo Interventional Systems (guidewires, catheters, stents, vascular closure devices), Terumo Hospital Care Solutions (smart infusion pumps, administration sets, syringes, hypodermic and dental needles), Terumo Pharmaceutical Solutions (drug administration devices, syringe systems, safety devices), and Terumo Cardiovascular (membrane oxygenators, centrifugal pumps, cardioplegia systems, hemoconcentrators). Products are sold to hospitals, clinics, and healthcare professionals across Brazil and the broader Latin American region.

Product overview

Terumo is a Japanese medical device corporation (founded 1921) operating in more than 160 countries, with Terumo Medical do Brasil established in 1999. The company offers a diversified portfolio organized into four main divisions: Terumo Interventional Systems (TIS) providing technologies for minimally invasive interventional procedures including coronary, oncological, and peripheral interventions; Terumo Hospital Care Solutions offering disposable medical devices and controlled infusion therapy equipment including smart infusion pumps, administration sets, syringes, and needles; Terumo Pharmaceutical Solutions Division manufacturing drug administration devices including syringe systems and safety devices; and Terumo Cardiovascular manufacturing devices for cardiac and vascular surgery including extracorporeal circulation products, membrane oxygenators, centrifugal pumps, and cardioplegia systems. The Terufusion branded infusion systems integrate with dedicated administration sets, and products are regulated by ANVISA with multiple registration numbers documented. The company demonstrates commitment to data protection compliance under Brazil's LGPD (Lei Geral de Proteção de Dados 13.709/2018) and maintains international data transfer policies aligned with data protection principles.

Differentiator

Problem solved

Functional benefit

Brands

• Terumo Interventional Systems: Division specializing in minimally invasive interventional access technologies, including coronary, oncological, and peripheral interventions.
• Terumo Hospital Care Solutions
• Terumo Pharmaceutical Solutions Division
• Terumo Cardiovascular

Products and services

• Terumo Interventional Systems Market-leading portfolio for minimally invasive access including coronary, oncological and peripheral interventions, with strategic focus on Transradial Access and Complex Coronary Intervention. Targeted at interventional cardiologists, radiologists and vascular surgeons.
• Terumo Hospital Care Solutions Provides disposable medical devices and controlled infusion therapy equipment (infusion pumps, administration sets, hypodermic and dental needles) for hospital wards and intensive care units. Designed for healthcare professionals delivering safe patient care and medication administration.
• Terumo Pharmaceutical Solutions Division Manufactures drug administration devices including syringe systems, hypodermic needles, catheters and safety infusion sets for pharmaceutical, biological, and consumer health clients.
• Terumo Cardiovascular Manufactures medical devices for cardiac and vascular surgery with emphasis on extracorporeal circulation, intraoperative monitoring, perfusion systems, blood gas monitoring, endoscopic vessel removal and surgical stabilization.
• CAPIOX Hollow Fiber Membrane Oxygenators

Quantifiable outcome

• Reduced hemodilution and blood transfusions through low-volume oxygenators
• +1 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Scale indicators4 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Abbott: Direct competitor in interventional cardiology (drug-eluting stents, structural heart) and diagnostics. Abbott has a strong Brazilian presence that overlaps with Terumo's interventional and cardiovascular divisions.
• Dräger: Direct competitor in anesthesia delivery and hospital monitoring equipment. Dräger competes with Terumo's anesthesia pump (TE-SS 830 TCI) and adjacent hospital care products in Brazilian hospitals.
• Boston Scientific: Direct competitor in interventional cardiology and peripheral vascular devices. Boston Scientific competes head-to-head with Terumo's interventional division in stents, microcatheters, and guidewires across the Brazilian market.
• Medtronic: Direct competitor across interventional cardiology, structural heart, and surgical devices. Medtronic's Brazilian operations compete with Terumo on stents, catheters, and cardiovascular surgery products.
• B. Braun: Direct competitor in infusion pumps, administration sets, syringes, and hospital care products. B. Braun has a manufacturing footprint in Brazil that overlaps with Terumo's Hospital Care Solutions division.
• Edwards Lifesciences: Direct competitor in cardiovascular surgery and heart valve products. Edwards competes with Terumo Cardiovascular in cardiac surgery and perfusion-related devices in Brazil.
• Becton Dickinson (BD): Direct competitor in syringes, needles, infusion therapy, and hospital disposables. BD's Brazilian operations directly overlap with Terumo's Hospital Care Solutions and Pharmaceutical Solutions divisions.

Broad incumbents

• Johnson & Johnson MedTech: Broad incumbent competing across interventional cardiology, surgical devices, and hospital products through its MedTech division. J&J's Brazilian operations overlap with multiple Terumo divisions as part of a wider portfolio play.
• Philips (Healthcare): Broad incumbent in medical imaging, patient monitoring, and interventional guidance systems. Philips competes with Terumo's cardiovascular and interventional imaging (OFDI) categories as part of a larger healthcare portfolio.

Emerging players

• Mindray: Emerging player in patient monitoring, infusion pumps, and hospital care devices. Mindray is expanding its Latin American presence with cost-competitive products that increasingly overlap with Terumo's Hospital Care Solutions portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/terumo-latin-america/posts/?feedView=all
• Xx.com/TerumoLATAM
• Facebookfacebook.com/terumoindia

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Terumo